Involvement of 15-lipoxygenase-1 in the regulation of breast cancer cell death induced by sodium butyrate

Cytotechnology

Volumn 68, Issue 6, 2016, Pages 2519-2528

  Salimi, Vahid ^a   Shabani, Mohammad ^b   Nourbakhsh, Mitra ^b,c   Tavakoli Yaraki, Masoumeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

15 Lipoxygenase 1; Apoptosis; Cell cytotoxicity; Sodium butyrate

Indexed keywords

13 S HYDROXYOCTADECADIENOIC ACID; 15 LIPOXYGENASE 1; ARACHIDONATE 15 LIPOXYGENASE; BUTYRIC ACID; FATTY ACID; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; LIPOXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MOLECULAR BIOLOGY; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; STAINING;

EID: 84966701592     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-016-9972-3     Document Type: Article

References (35)

1. Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769–784. doi:10.1038/nrd2133
2. Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274:23679–23682
3. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM (2006) The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal 18:9–20
4. Cao QF, Qian SB, Wang N, Zhang L, Wang WM, Shen HB (2015) TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells. Cancer Biother Radiopharm 30:87–93. doi:10.1089/cbr.2014.1697
5. Comba A, Maestri DM, Berra MA, Garcia CP, Das UN, Eynard AR, Pasqualini ME (2010) Effect of omega-3 and omega-9 fatty acid rich oils on lipoxygenases and cyclooxygenases enzymes and on the growth of a mammary adenocarcinoma model. Lipids Health Dis 9:112
6. Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485s–2493s
7. Fallahian F, Karami-Tehrani F, Salami S (2012) Induction of apoptosis by type Ibeta protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468. Cell Biochem Funct 30:183–190. doi:10.1002/cbf.1831
8. Feng Y, Bai X, Yang Q, Wu H, Wang D (2010) Downregulation of 15-lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells. Int J Oncol 36:1541–1549
9. Giancotti V (2006) Breast cancer markers. Cancer Lett 243:145–159
10. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32–42. doi:10.1038/nrg2485
11. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F, Furstenberger G, Buchler MW, Friess H, Krieg P, Adrian TE (2007) 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia 9:917–926
12. Hoshyar R, Mahboob Z, Zarban A (2015) The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells. Cytotechnology. doi:10.1007/s10616-015-9880-y
13. Hsi LC, Wilson LC, Eling TE (2002) Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate alteration in peroxisome proliferator-activated receptor gamma. J Biol Chem 277:40549–40556. doi:10.1074/jbc.M203522200
14. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM (2004) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 64:8778–8781
15. Jiang WG, Watkins G, Douglas-Jones A, Mansel RE (2006) Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer. Prostaglandins Leukot Essent Fat Acids 74:235–245
16. Kasibhatla S, Tseng B (2003) Why target apoptosis in cancer treatment? Mol Cancer Ther 2:573–580
17. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hammerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D, Krupitza G (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J clin Invest 121:2000–2012. doi:10.1172/jci44751
18. Lambrechts S, Decloedt J, Neven P (2011) Breast cancer prevention: lifestyle changes and chemoprevention. Acta Clin Belg 66:283–292
19. Lane AA, Chabner BA (2009) Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 27:5459–5468
20. Li Z, Wang Y, Yuan C, Zhu Y, Qiu J, Zhang W, Qi B, Wu H, Ye J, Jiang H, Yang J, Cheng J (2014) oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Lab Invest 94:1431–1445. doi:10.1038/labinvest.2014.123
21. Li L, Sun Y, Liu J, Wu X, Chen L, Ma L, Wu P (2015) Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells. BMC Biochem 16:2. doi:10.1186/s12858-014-0030-5
22. Liu C, Schain F, Han H, Xu D, Andersson-Sand H, Forsell P, Claesson HE, Bjorkholm M, Sjoberg J (2015) Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line. Exp Cell Res 318:169–176
23. Margueron R, Duong V, Castet A, Cavailles V (2004) Histone deacetylase inhibition and estrogen signalling in human breast cancer cells. Biochem Pharmacol 68:1239–1246
24. Natoni F, Diolordi L, Santoni C, Gilardini Montani MS (2005) Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways. Biochim Biophys Acta 1745:318–329. doi:10.1016/j.bbamcr.2005.07.003
25. Paskova L, Smesny Trtkova K, Fialova B, Benedikova A, Langova K, Kolar Z (2013) Different effect of sodium butyrate on cancer and normal prostate cells. Toxicol In Vitro 27:1489–1495. doi:10.1016/j.tiv.2013.03.002
26. Rodrigues MF, Carvalho E, Pezzuto P, Rumjanek FD, Amoedo ND (2013) Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin a on the energy metabolism of breast cancer cells. J Cell Biochem 116:797–808. doi:10.1002/jcb.25036
27. Salimi V, Tavakoli-Yaraki M, Mahmoodi M, Shahabi S, Gharagozlou MJ, Shokri F, Mokhtari-Azad T (2013) The oncolytic effect of respiratory syncytial virus (RSV) in human skin cancer cell line, A431. Iran Red Crescent Med J 15:62–67. doi:10.5812/ircmj.4722
28. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ, Daugherty A (1997) Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120:1199–1206. doi:10.1038/sj.bjp.0701007
29. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, Brenner DE (1999) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20:1985–1995
30. Suraneni MV, Moore JR, Zhang D, Badeaux M, Macaluso MD, Giovanni J, Kusewitt D, Tang DG (2014) Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer. Cell Cycle 13:1798–1810. doi:10.4161/cc.28757
31. Tang Y, Wang MT, Chen Y, Yang D, Che M, Honn KV, Akers GD, Johnson SR, Nie D (2009) Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer. Int J Cancer 124:1545–1551. doi:10.1002/ijc.24118
32. Tavakoli Yaraki M, Karami Tehrani F (2013) Apoptosis Induced by 13-S-hydroxyoctadecadienoic acid in the breast cancer cell lines, MCF-7 and MDA-MB-231. IJBMS 16:653–659
33. Tavakoli-Yaraki M, Karami-Tehrani F, Salimi V, Sirati-Sabet M (2013) Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1. Tumour Biol 34:241–249. doi:10.1007/s13277-012-0544-7
34. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM (2003) Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia 5:121–127
35. Yuan H, Li MY, Ma LT, Hsin MK, Mok TS, Underwood MJ, Chen GG (2010) 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer. Thorax 65:321–326